mRNA

Pfizer has been sued for infringing on patent technology for the COVID-19 mRNA vaccines, developed by Arbutus Biopharma.

"Largest crime scene in history."

The World Health Organization acknowledged there are "comparatively low public health returns" for some groups receiving the COVID-19 booster.

The UK's Office for National Statistics (ONS) senior statistician Vahé Nafilyan said research has found “receiving a first dose of a non-mRNA vaccine was associated with an increased risk of cardiac death in young women.”

Former chief judge of the U.S. Court of Federal Claims Susan Braden said the federal government's "statement of interest" in a Moderna lawsuit may present a "misuse of the law."

"People aren't really opposed, but they do need a push, a push and a drag," joked DC Mayor Muriel Bowser.

Confidential documents from Pfizer reveal that the company was aware of potential risks of myocarditis following COVID-19 vaccinations in early 2022.

The meta-analysis claims, "The level of protection against re-infection, symptomatic disease, and severe disease appears to be at least as durable, if not more so, than that provided by two-dose vaccination with the mRNA vaccines."

The Biden administration, through Delaware U.S. Attorney David Weiss, filed a statement of interest in a case alleging Moderna stole intellectual property from biotech companies Arbutus and Genevant.

A case report in the medical journal Frontiers in Immunology highlights a rare case of a patient developing rheumatoid encephalitis after receiving a booster immunization of the mRNA-1273 COVID-19 vaccine, raising concerns about potential adverse reactions to the vaccine.